How can we help you?
The latest from MDFA
MDFA response to Federal Budget announcement 2025-26
Macular Disease Foundation Australia (MDFA) is pleased with the Federal Government’s increased investment to make primary health care more affordable and accessible for Australians doing it tough due to the current cost of living crisis.
Our latest newsletter is out now
Read the Autumn 2025 edition of the Vision Voice newsletter.
Government defers MBS private health insurance reclassification
Macular Disease Foundation Australia (MDFA) has welcomed the Federal Government’s decision to defer the private health insurance reclassification of intravitreal (eye) injections from 1 July 2025 to 1 July 2026 and undertake further consultation.
-
Call to Federal Government to bulk bill eye injections for pensioners
We have released new research in collaboration with the University of New South Wales which has revealed the median total cost for people living with macular disease, who also receive sight-saving eye injections, is 12 percent* ($3,621) of the annual government pension payment.
Opinion Editorial: Sight preservation should be a national priority
By The Hon. Jillian Skinner, AM, former NSW Minister for Health.This article was originally published by News Corp.
New treatment for Geographic Atrophy
The Therapeutic Goods Administration (TGA) approval of the new eye injection treatment SYFOVRE® (pegcetacoplan) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.
Our latest newsletter is out now
This is our annual research focused edition. In it you will find information about new macular disease treatments, geographic atrophy and innovations being explored to treat, preserve or improve sight.
Survey shows new Eye Connect service benefiting AMD community
MDFA has received a positive response from the people participating in our new Eye Connect support service.
MDFA showcases groundbreaking research projects in new impact report
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
This series of short videos answers the big questions about age-related macular degeneration, diabetic eye disease, your eye health and living with low vision.
Watch the videos
